Close Menu

NEW YORK – Adaptive Biotechnologies reported a 1 percent year-over-year increase in third quarter revenues after the close of the market on Tuesday.

For the three months ended Sept. 30, Adaptive reported $26.3 million in revenues, up from $26.1 million during the year-ago period and beating the consensus Wall Street estimate of $23.6 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.